12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
週三盤前交易時段，12只醫療保健股走勢
Gainers
獲勝者
- Novo Integrated Sciences (NASDAQ:NVOS) stock increased by 109.0% to $0.24 during Wednesday's pre-market session. The market value of their outstanding shares is at $35.9 million.
- MSP Recovery (NASDAQ:LIFW) stock rose 32.97% to $0.16. The market value of their outstanding shares is at $52.7 million.
- Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 20.97% to $0.4. The company's market cap stands at $15.2 million.
- Precision BioSciences (NASDAQ:DTIL) stock moved upwards by 16.87% to $0.62. The company's market cap stands at $71.3 million.
- T2 Biosystems (NASDAQ:TTOO) stock increased by 13.58% to $0.67. The company's market cap stands at $223.9 million.
- Tivic Health Systems (NASDAQ:TIVC) stock rose 12.63% to $0.04. The company's market cap stands at $6.1 million. As per the press release, Q2 earnings came out 2 days ago.
- Novo 綜合科學 納斯達克股票代碼：NVOS）股價在週三的盤前交易中上漲了109.0％，至0.24美元。他們已發行股票的市值爲3590萬美元。
- MSP 恢復 納斯達克股票代碼：LIFW）股價上漲32.97％，至0.16美元。他們已發行股票的市值爲5,270萬美元。
- 十四行詩生物療法 納斯達克股票代碼：SONN）股價上漲20.97％，至0.4美元。該公司的市值爲1,520萬美元。
- 精密生物科學 納斯達克股票代碼：DTIL）股價上漲16.87％，至0.62美元。該公司的市值爲7,130萬美元。
- T2 生物系統 納斯達克股票代碼：TTOO）的股票上漲了13.58％，至0.67美元。該公司的市值爲2.239億美元。
- Tivic 健康系統 納斯達克股票代碼：TIVC）股價上漲12.63％，至0.04美元。該公司的市值爲610萬美元。根據新聞稿，第二季度業績是在兩天前公佈的。
Losers
失敗者
- Impel Pharmaceuticals (NASDAQ:IMPL) stock fell 38.9% to $0.66 during Wednesday's pre-market session. The company's market cap stands at $15.6 million.
- RVL Pharmaceuticals (NASDAQ:RVLP) shares decreased by 23.81% to $0.32. The company's market cap stands at $31.7 million. The company's, Q2 earnings came out 2 days ago.
- G Medical Innovations (NASDAQ:GMVD) shares declined by 11.62% to $0.19. The market value of their outstanding shares is at $1.9 million.
- Oncternal Therapeutics (NASDAQ:ONCT) stock decreased by 9.82% to $0.34. The market value of their outstanding shares is at $20.0 million. As per the press release, Q2 earnings came out 4 days ago.
- Science 37 Hldgs (NASDAQ:SNCE) shares fell 9.73% to $0.3. The market value of their outstanding shares is at $35.1 million.
- Taysha Gene Therapies (NASDAQ:TSHA) stock declined by 9.11% to $1.98. The company's market cap stands at $127.1 million. As per the press release, Q2 earnings came out 2 days ago. See Also:
- Impel 製藥 納斯達克股票代碼：IMPL）股價在週三的盤前交易中下跌38.9％，至0.66美元。該公司的市值爲1,560萬美元。
- RVL 製藥 納斯達克股票代碼：RVLP）股價下跌23.81％，至0.32美元。該公司的市值爲3170萬美元。該公司的第二季度業績於兩天前公佈。
- G 醫療創新 納斯達克股票代碼：GMVD）股價下跌11.62％，至0.19美元。他們已發行股票的市值爲190萬美元。
- 體內療法 納斯達克股票代碼：ONCT）股價下跌9.82％，至0.34美元。他們的已發行股票的市值爲2,000萬美元。根據新聞稿，第二季度業績是在4天前公佈的。
- 科學 37 控股公司 納斯達克股票代碼：SNCE）股價下跌9.73％，至0.3美元。他們已發行股票的市值爲3510萬美元。
- Taysha 基因療法 納斯達克股票代碼：TSHA）股價下跌9.11％，至1.98美元。該公司的市值爲1.271億美元。根據新聞稿，第二季度業績是在兩天前公佈的。 另請參閱：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。